(Q35017572)

5 August 2017

title

Small-molecule modulators for epigenetics targets (English)

1 reference

5 August 2017

1 reference

Stefan Knapp

1

0 references

author name string

Hilmar Weinmann

series ordinal

2

1 reference

5 August 2017

publication date

14 October 2013

1 reference

5 August 2017

1 reference

5 August 2017

volume

8

1 reference

5 August 2017

issue

11

1 reference

5 August 2017

page(s)

1885-1891

1 reference

A decade of exploring the cancer epigenome - biological and translational implications

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

The future of epigenetic therapy in solid tumours--lessons from the past.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

Epigenetic modifications as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

Epigenetic regulation of the neural transcriptome: the meaning of the marks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

Epigenetic modifications and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

Epigenetic control of plant stress response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

Chromatin as an expansive canvas for chemical biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

Stability of nucleosomes containing homogenously ubiquitylated H2A and H2B prepared using semisynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

Epigenetic chemical probes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

Histone recognition and large-scale structural analysis of the human bromodomain family

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

Selective inhibition of BET bromodomains

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

Discovery and characterization of small molecule inhibitors of the BET family bromodomains

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

Fragment-based discovery of bromodomain inhibitors part 1: inhibitor binding modes and implications for lead discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

Fragment-based discovery of bromodomain inhibitors part 2: optimization of phenylisoxazole sulfonamides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

Protein methyltransferases as a target class for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

Structural chemistry of the histone methyltransferases cofactor binding site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

Conformational adaptation drives potent, selective and durable inhibition of the human protein methyltransferase DOT1L

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

Strategy to target the substrate binding site of SET domain protein methyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

Small-molecule inhibition of MLL activity by disruption of its interaction with WDR5

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

ChromoHub: a data hub for navigators of chromatin-mediated signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

Targeting genetic alterations in protein methyltransferases for personalized cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

Potent inhibition of DOT1L as treatment of MLL-fusion leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

Optimization of cellular activity of G9a inhibitors 7-aminoalkoxy-quinazolines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

An allosteric inhibitor of protein arginine methyltransferase 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

Exploiting an allosteric binding site of PRMT3 yields potent and selective inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

An orally bioavailable chemical probe of the Lysine Methyltransferases EZH2 and EZH1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

Identification of a Chemical Probe for Bromo and Extra C-Terminal Bromodomain Inhibition through Optimization of a Fragment-Derived Hit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

Crystal structure and functional analysis of the histone methyltransferase SET7/9

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

Structural basis of substrate methylation and inhibition of SMYD2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

Carbamate prodrug concept for hydroxamate HDAC inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

Lysine demethylases inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

LSD1 inhibition: a therapeutic strategy in cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

Impairment of prostate cancer cell growth by a selective and reversible lysine-specific demethylase 1 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

The influence of the 'organizational factor' on compound quality in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

Optimization of 3,5-Dimethylisoxazole Derivatives as Potent Bromodomain Ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

inferred from DOI database lookup

7 January 2021

based on heuristic

Getting pharmaceutical R&D back on target

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

inferred from DOI database lookup

7 January 2021

based on heuristic

Discovery of an allosteric mechanism for the regulation of HCV NS3 protein function

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300344

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CMDC.201300344

1 reference

5 August 2017

1 reference